REAL-WORLD COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN SYMPTOMATIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN PORTUGAL

被引：0
|
作者：
Afonso-Silva, M. [1 ]
Laires, P. A. [1 ]
机构：
[1] Prod Farmaceut SA, Novartis Farma, Porto Salvo, Portugal
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV24
引用
收藏
页码：S545 / S545
页数：1
相关论文
共 50 条
  • [41] The cost-effectiveness of sacubitril/valsartan (LCZ696) in the treatment of patients with heart failure with reduced ejection fraction in Norway
    Gundersen, V.
    Eklund, O.
    Hancock, E.
    Hussain, R.
    Ohna, A.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 203 - 203
  • [42] Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand
    Krittayaphong, Rungroj
    Permsuwan, Unchalee
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (05) : 405 - 413
  • [43] Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand
    Rungroj Krittayaphong
    Unchalee Permsuwan
    [J]. American Journal of Cardiovascular Drugs, 2018, 18 : 405 - 413
  • [44] Real-World Safety of Sacubitril/Valsartan in Women and Men With Heart Failure and Reduced Ejection Fraction: A Meta-analysis
    Nuechterlein, Kaitlin
    AlTurki, Ahmed
    Ni, Jiayi
    Martinez-Selles, Manuel
    Martens, Pieter
    Russo, Vincenzo
    Backelin, Charlotte Nordberg
    Huynh, Thao
    [J]. CJC OPEN, 2021, 3 (12) : S202 - S208
  • [45] Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry
    Zeymer, Uwe
    Clark, Andrew L.
    Barrios, Vivencio
    Damy, Thibaud
    Drozdz, Jaroslaw
    Fonseca, Candisda
    Lund, Lars H.
    Kalus, Stefanie
    Ferber, Philippe C.
    Hussain, Rizwan, I
    Koch, Cornelia
    Maggioni, Aldo P.
    [J]. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (04) : 469 - 477
  • [46] Real-World Analysis of Diuretic Requirements in Patients with Heart Failure with Reduced Ejection Fraction after Initiation of Sacubitril/Valsartan
    Miah, A.
    Ahmed, U.
    Pirlamarla, P.
    Reeves, G.
    Abbas, C.
    Shah, M.
    Alvarez, R.
    Cozzi, S.
    Demastus, C.
    Ervin, A.
    Danelich, I.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S152 - S153
  • [47] Sacubitril/Valsartan in the Treatment of Right Ventricular Dysfunction in Patients With Heart Failure With Reduced Ejection Fraction: A Real-world Study
    Yang, Ying
    Shen, Chao
    Lu, Jiangting
    Fu, Guosheng
    Xiong, Cui
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 177 - 182
  • [48] Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction With a Recent Worsening Heart Failure Event
    Dixit, Neal
    Truong, Katie
    Ziaeian, Boback
    Fonarow, Gregg C.
    [J]. CIRCULATION, 2023, 148
  • [49] Effectiveness of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Using Real-World Data: An Updated Systematic Review and Meta-Analysis
    Rahhal, Alaa
    Kasem, Mohamed
    Orabi, Bassant
    Hamou, Fatima
    Abuyousef, Safae
    Mahfouz, Ahmed
    Alyafei, Sumaya
    Shoukry, Ahmed Emad
    Ahmed, Emad
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (01)
  • [50] Use of Sacubitril/Valsartan in heart failure with reduced ejection fraction
    吴利强
    冯慧婷
    冯慧娟
    [J]. South China Journal of Cardiology, 2019, 20 (04) : 252 - 257
12345